Publicacións nas que colabora con Juan Luis García Hernández (24)

2022

  1. Molecular Dissection of Structural Variations Involved in Antithrombin Deficiency

    Journal of Molecular Diagnostics, Vol. 24, Núm. 5, pp. 462-475

2020

  1. CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

    Leukemia, Vol. 34, Núm. 6, pp. 1599-1612

2019

  1. Clinical, cytogenetic, and molecular findings in a patient with ring chromosome 4: Case report and literature review

    BMC Medical Genomics, Vol. 12, Núm. 1

2016

  1. Chromothripsis is a recurrent genomic abnormality in high-risk myelodysplastic syndromes

    PLoS ONE, Vol. 11, Núm. 10

  2. Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome

    PloS one, Vol. 11, Núm. 2, pp. e0148972

  3. Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse

    Oncotarget, Vol. 7, Núm. 49, pp. 80664-80679

  4. The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab

    British journal of haematology, Vol. 172, Núm. 3, pp. 428-438

  5. Uniparental disomy causes deficiencies of vitamin K-dependent proteins

    Journal of Thrombosis and Haemostasis, Vol. 14, Núm. 12, pp. 2410-2418

2015

  1. MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL

    BMC Cancer, Vol. 15, Núm. 1

2014

  1. Genomic analysis of clonal eosinophils by CGH arrays reveals new genetic regions involved in chronic eosinophilia

    European Journal of Haematology, Vol. 93, Núm. 5, pp. 422-428

  2. TET2 overexpression in chronic lymphocytic leukemia is unrelated to the presence of TET2 variations

    BioMed Research International, Vol. 2014

2013

  1. Clinical applications of BAC array-CGH to the study of diffuse large B-cell lymphomas

    Methods in Molecular Biology, Vol. 973, pp. 121-145

  2. Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes

    Leukemia, Vol. 27, Núm. 3, pp. 610-618

2012

  1. Incidence and clinical characteristics of myeloproliferative neoplasms displaying a PDGFRB rearrangement

    European Journal of Haematology, Vol. 89, Núm. 1, pp. 37-41

  2. Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14

    PLoS ONE, Vol. 7, Núm. 11

  3. Response to imatinib mesylate in patients with hypereosinophilic syndrome

    International Journal of Hematology, Vol. 96, Núm. 3, pp. 320-326

2010

  1. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma

    Genes Chromosomes and Cancer, Vol. 49, Núm. 5, pp. 439-451

  2. Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas

    BMC Cancer, Vol. 10

2009

  1. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome

    Leukemia, Vol. 23, Núm. 4, pp. 664-672

1997

  1. Anomalies of chromosomes 17 and 22 in giant cell fibroblastoma

    Cancer Genetics and Cytogenetics, Vol. 97, Núm. 2, pp. 165-166